OptiNose, Inc. (OPTN)

USD 9.05

(-0.54%)

Long Term Debt Summary of OptiNose, Inc.

  • OptiNose, Inc.'s latest annual long term debt in 2023 was 611 Thousand USD , down -2.24% from previous year.
  • OptiNose, Inc.'s latest quarterly long term debt in 2024 Q2 was 125.29 Million USD , down -4.1% from previous quarter.
  • OptiNose, Inc. reported annual long term debt of 625 Thousand USD in 2022, down -99.51% from previous year.
  • OptiNose, Inc. reported annual long term debt of 128.6 Million USD in 2021, up 2.72% from previous year.
  • OptiNose, Inc. reported quarterly long term debt of 130.65 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • OptiNose, Inc. reported quarterly long term debt of 611 Thousand USD for 2023 Q4, down -17.54% from previous quarter.

Annual Long Term Debt Chart of OptiNose, Inc. (2023 - 2015)

Historical Annual Long Term Debt of OptiNose, Inc. (2023 - 2015)

Year Long Term Debt Long Term Debt Growth
2023 611 Thousand USD -2.24%
2022 625 Thousand USD -99.51%
2021 128.6 Million USD 2.72%
2020 125.2 Million USD 67.99%
2019 74.53 Million USD 2.8%
2018 72.5 Million USD 0.89%
2017 71.86 Million USD 371.05%
2016 15.25 Million USD 5.36%
2015 14.48 Million USD 0.0%

Peer Long Term Debt Comparison of OptiNose, Inc.

Name Long Term Debt Long Term Debt Difference
ANI Pharmaceuticals, Inc. 309.66 Million USD 99.803%
Aquestive Therapeutics, Inc. 91.07 Million USD 99.329%
Collegium Pharmaceutical, Inc. 489.96 Million USD 99.875%
Dynavax Technologies Corporation 252.41 Million USD 99.758%
Esperion Therapeutics, Inc. 501.54 Million USD 99.878%
Cosmos Health Inc. 3.03 Million USD 79.87%
Pacira BioSciences, Inc. 513.79 Million USD 99.881%
PainReform Ltd. 30 Thousand USD -1936.667%
Sunshine Biopharma, Inc. 539.03 Thousand USD -13.351%
Sunshine Biopharma, Inc. 539.03 Thousand USD -13.351%
SCYNEXIS, Inc. 12.15 Million USD 94.975%
Safety Shot Inc 304.9 Thousand USD -100.389%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -421.647%
Alpha Teknova, Inc. 13.25 Million USD 95.389%
Embecta Corp. 1.62 Billion USD 99.962%
Bright Green Corporation 201.78 Thousand USD -202.801%
Intra-Cellular Therapies, Inc. 13.32 Million USD 95.415%
Journey Medical Corporation 14.62 Million USD 95.821%
Procaps Group, S.A. 28.41 Million USD 97.849%
Theratechnologies Inc. 51.26 Million USD 98.808%
Harrow Health, Inc. 183.17 Million USD 99.666%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -602.299%
Biofrontera Inc. 804 Thousand USD 24.005%
DURECT Corporation 2.7 Million USD 77.387%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 98.159%
Cronos Group Inc. 1.55 Million USD 60.808%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 99.877%
Kala Pharmaceuticals, Inc. 34.19 Million USD 98.213%
RedHill Biopharma Ltd. 455 Thousand USD -34.286%
Organogenesis Holdings Inc. 60.74 Million USD 98.994%
Guardion Health Sciences, Inc. - USD -Infinity%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 95.221%
Radius Health, Inc. 339.66 Million USD 99.82%
Universe Pharmaceuticals INC - USD -Infinity%
ProPhase Labs, Inc. 10.25 Million USD 94.044%
Phibro Animal Health Corporation 458.28 Million USD 99.867%
Procaps Group S.A. 28.41 Million USD 97.849%
Alvotech 1.02 Billion USD 99.941%
TherapeuticsMD, Inc. 6.53 Million USD 90.646%
Viatris Inc. 16.18 Billion USD 99.996%
Rockwell Medical, Inc. 8.29 Million USD 92.632%
Aytu BioPharma, Inc. 10.87 Million USD 94.383%
SIGA Technologies, Inc. 335.99 Thousand USD -81.85%
Tilray Brands, Inc. 287.93 Million USD 99.788%
Lifecore Biomedical, Inc. 120.51 Million USD 99.493%
Shineco, Inc. 10.01 Million USD 93.901%
PetIQ, Inc. 437.82 Million USD 99.86%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 210 Thousand USD -190.952%
Neurocrine Biosciences, Inc. 258.3 Million USD 99.763%
Alimera Sciences, Inc. 64.48 Million USD 99.053%
Silver Spike Investment Corp. - USD -Infinity%
Assertio Holdings, Inc. 38.51 Million USD 98.414%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -352.294%
Petros Pharmaceuticals, Inc. 6.85 Million USD 91.09%
Clever Leaves Holdings Inc. 720 Thousand USD 15.139%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -2617.488%
Avadel Pharmaceuticals plc 32.75 Million USD 98.135%
Hempacco Co., Inc. 5.93 Million USD 89.698%
Talphera, Inc. - USD -Infinity%
Alvotech 1.02 Billion USD 99.941%
Eagle Pharmaceuticals, Inc. 56.21 Million USD 98.913%
Lantheus Holdings, Inc. 616.12 Million USD 99.901%
Currenc Group, Inc. 2.5 Million USD 75.628%
Kamada Ltd. 7.43 Million USD 91.785%
Indivior PLC 235.66 Million USD 99.741%
Evoke Pharma, Inc. 5 Million USD 87.78%
Flora Growth Corp. 942 Thousand USD 35.138%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -2617.488%
Evolus, Inc. 120.35 Million USD 99.492%
HUTCHMED (China) Limited 48.18 Million USD 98.732%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 99.896%
Akanda Corp. 2.49 Million USD 75.532%